Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population

Journal of Hypertension

Volumn 23, Issue 3, 2005, Pages 513-520

  Bombelli, Michele ^a   Sega, Roberto ^b   Facchetti, Rita ^b   Corrao, Giovanni ^b   Friz, Hernan Polo ^b   Vertemati, Andrea Maria ^a   Sanvito, Riccardo ^a   Banfi, Elena ^a   Carugo, Stefano ^d   Primitz, Laura ^b   Mancia, Giuseppe ^a,c,d  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Ambulatory blood pressure; Hypertension; Left ventricular hypertrophy; White coat effect

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SPHYGMOMANOMETRY; STATISTICAL SIGNIFICANCE; WHITE COAT HYPERTENSION;

EID: 21044459001     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000160206.58781.07     Document Type: Article

References (32)

1. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.
2. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000; 19:1981-1989.
3. Imai Y, Ohkubo T, Tsuji I, Hozawa A, Nagai K, Kikuya M, et al. Relationships among blood pressures obtained using different measurement methods in the general population of Ohasama, Japan. Hypertens Res 1999; 22:261-272.
4. Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens; 2003; 21:1011-1053.
5. Pickering TG. Clinical applications of ambulatory blood pressure monitoring: the white coat syndrome. Clin Invest Med 1991; 14:212-217.
6. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000; 36:894-900.
7. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Hinman Circ 1966; 34:279-298.
8. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens Suppl 1989; 7:S3-S10.
9. Owens PE, Lyons SP, Rodriguez SA, O'Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Hum Hypertens 1998; 12:743-748.
10. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni (PAMELA) Study). Circulation 2001; 18:1385-1392.
11. Muscholl MW, Hense HW, Brockel U, Doring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 29:565-570.
12. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, Pessina AC. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.
13. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension: not guilty when correctly defined. Stood Press Monit 1998; 3:147-152.
14. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
15. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, Mezzetti A. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
16. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW. White-coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. J Hum Hypertens 1998; 12:433-439.
17. Rizzo V, Cicconetti P, Bianchi A, Lorido A, Morelli S, Vetta F, et al. White-coat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens 1996; 10:293-298.
18. Parati G, Ulian L, Sampieri P, Palatini A, Villani A, Vanasia G, Mancia G. Attenuation of the 'white coat' effect by antihypertensive treatment and regression of target organ damage. Hypertension 2000; 35:614-620.
19. Wing LM, Brown MA, Beilin LJ, Ryan P, Reid CM. ANBP2 Management Committee and Investigators. Second Australian National Blood Pressure Study. 'Reverse white-coat hypertension' in older hypertensives. J Hypertens 2002; 20:639-644.
20. Devereux RB. Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension. Am J Hypertens 1989; 2:650-654.
21. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
24. Dubois D, Dubois EF. A formula to estimate the approximative surface area if height and weight are known. Arch Intern Med 1916; 17:863-871.
25. Hernandez del-Rey R, Armario P, Martin-Baranera M, Sanchez P, Almendros MC, Coca A, Pardell H. Cardiac damage in hypertensive patients with inverse white coat hypertension. Hospitalet study. Blood Press 2003; 12:89-96.
26. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997; 15:454-457.
27. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22:435-445.
28. Mancia G. Reversed white-coat hypertension: definition, mechanisms and prognostic implications. J Hypertens 2002; 20:579-581.
29. Robertson JI. Reversed white-coat hypertension: not what it seems. J Hypertens 2002; 20:1669.
30. Parati G, Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension 1985; 7:597-601.
31. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 24:695-698.
32. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998; 31:1185-1189.